{"url_path":"/sec/exoz/8-k/2026-06-17/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/2010788/0001493152-26-029119-index.html","accession_number":"0001493152-26-029119","cik":"0002010788","ticker":"EXOZ","issuer_name":"EXOZYMES INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2010788/0001493152-26-029119-index.html","primary_entity_key":"0002010788","primary_entity_name":"EXOZYMES INC."},"word_count":165,"has_tables":true,"body_markdown":"**Item\n9.01.**\n**Financial\nStatements and Exhibits.**\n\n \n\n**(d)\nExhibits**\n\n \n\nExhibits\n \nDescription\nof Exhibit\n\n \n \n \n\n5.1\n**\n \n[Opinion of Spencer Fane LLP, dated June 5, 2026 (relating to the Shares)](https://www.sec.gov/Archives/edgar/data/2010788/000149315226027688/ex5-1.htm)\n\n \n \n \n\n10.1\n**\n \n[Underwriting Agreement between the Registrant and MDB Capital, dated June 5, 2026](https://www.sec.gov/Archives/edgar/data/2010788/000149315226027688/ex10-1.htm)\n\n \n \n \n\n10.2\n**\n \n[Warrant Agent Agreement between the Registrant and VStock Transfer, LLC dated June 5, 2026](https://www.sec.gov/Archives/edgar/data/2010788/000149315226027688/ex10-2.htm)\n\n \n \n \n\n10.3\n**\n \n[Underwriter’s Warrant Agreement, dated June 9, 2026](https://www.sec.gov/Archives/edgar/data/2010788/000149315226027688/ex10-3.htm)\n\n \n \n \n\n23.1\n**\n \n[Consent of Spencer Fane LLP (contained in Exhibit 5.1)](https://www.sec.gov/Archives/edgar/data/2010788/000149315226027688/ex5-1.htm)\n\n \n \n \n\n99.1\n*\n \n[Press Release, dated June 17, 2026](ex99-1.htm)\n\n \n \n \n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL Document).\n\n \n\n*\nFiled\nherewith\n\n**\nIncorporated\nby reference to the Exhibits 5.1, 10.1, 10.2, 10.3 and 23.1, respectively, filed with the Current Report of the Registrant filed\non June 8, 2026.\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\nDate:\nJune 17, 2026\nEXOZYMES\nINC.\n\n \n \n \n\n \nBy\n*/s/\nFouad Nawaz*\n\n \n \nFouad\nNawaz,\n\n \n \nVice\nPresident, Finance\n\n \n\n \n\n** **"}